Sanofi (SNY) - Quarterly EPS earnings growth

Corporate company logo of Sanofi (SNY)

The active acquisition of biotech startups expands the capacities of Sanofi (SNY), which correlates with the quarterly EPS chart. The value of -31.70 shows the latest reading of this indicator. Financial stability is based on inelastic demand within the defensive sector, while the flawless image of the European leader ensures long-term investor confidence in the holding's assets.

sanofi.com (SNY) Year-over-year earnings per share growth for the last 12 months: for the period 07/04/2022 - 11/15/2026

Summary analytical data breakdowns for Sanofi (SNY)

- share price and expert price forecast:
Stock Price Sanofi|SNY - Broker Consensus Forecast
- market capitalization indicators:
Market Capitalization Sanofi SA|SNY - Company Buyout Price
- balance sheet net asset value indicators:
Net Assets per Single Share Sanofi|SNY - Accounting Capitalization|Market Capitalization to Book Value Ratio sanofi.com|SNY - Company Balance Sheet Assets
- debt level and financial liquidity data:
Debt to Equity Sanofi|SNY - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital sanofi.com|SNY - Company Aggregate Debts|Debt to Book Capitalization Ratio Sanofi SA|SNY - Company Long-Term Indebtedness|Company Short-Term Debt Sanofi|Quick Ratio sanofi.com
- earnings and market multiples details:
SNY - Profit After Tax|Projected Future Earnings Sanofi|SNY - Business Payback Period|Future Price to Earnings sanofi.com|SNY - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Sanofi SA|SNY - Operating profit before amortization|Net earnings per share for the last 12 months Sanofi|SNY - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months sanofi.com|SNY - Earnings per share trend in current year|Earnings growth forecast for next year Sanofi
- company sales and revenue statistics:
SNY - Company Sales Revenue|Projected Sales Volume Sanofi SA|SNY - P/S Multiple|Price-to-Projected Revenue Ratio Sanofi S.A.|SNY - Revenue Dynamics YoY (Last Twelve Months)
Initial company analysis:Sanofi
Manufactured product of Sanofi Group

This indicator measures the rate of change in net earnings per share, smoothing out temporary gaps between reporting periods. Growth in this metric signals effective capital management and operational profitability. By analyzing quarterly earnings per share dynamics, an investor assesses the business's resilience to market volatility. The current trend reflects the impact of capacity modernization at Sanofi (SNY). Automation of filling processes and the expansion of the vaccine portfolio should ensure long-term profit growth.

Key competitors

LLY: Quarterly EPS earnings growth|ABBV (Abbvie) - Year-over-year earnings per share growth for the last twelve months|AZN (astrazeneca.com) - Quarterly EPS earnings growth|novartis.com (NVS) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Merck Sharp & Dohme (MRK)|Novo Nordisk - Year-over-year earnings per share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Amgen Inc. AMGN|Net earnings per share growth for the trailing year Pfizer Corp|Bristol-Myers Squibb - Quarterly EPS earnings growth|Net earnings per share growth for the trailing year GlaxoSmithKline (GSK)|TAK: Quarterly EPS earnings growth|TEVA: Year-over-year earnings per share growth rate for the last twelve months|Year-over-year net earnings per share growth for the last 12 months RDY|Viatris Corp (VTRS) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth ROIV|Year-over-year net earnings per share change for the last twelve months Zai Lab|Quarterly EPS earnings growth BHC (Bausch Health Companies Inc.)|COSM - Year-over-year net earnings per share growth for the last 12 months